» Articles » PMID: 39843961

Analysis of Retinal Sublayers in Patients with Systemic COVID-19 Illness with Varying Degrees of Severity

Overview
Journal Sci Rep
Date 2025 Jan 22
PMID 39843961
Authors
Affiliations
Soon will be listed here.
Abstract

COVID-19 infection has been linked to ocular involvement, particularly retinal microvascular changes. Additionally, prolonged hypoxemia may affect retinal sublayers located within the retinal watershed zone. The aim of this study was to evaluate retinal and optic nerve OCT parameters in patients with COVID-19 illness of varying severity and compare them with controls. In this prospective case-control study, a total of 78 consecutive patients who had recently recovered from SARS-CoV-2 infection (29 outpatients, 32 ward-admitted patients, and 17 ICU-admitted patients) were included, along with 85 controls. All participants had no ocular disease or symptoms. Spectralis SD-OCT scans of the macula and optic nerve were obtained from all participants 6 weeks after initial diagnosis. The central subfield thickness of the macula (CSFT), peripapillary retinal nerve fiber layer thickness (pRNFL), and retinal sublayers' volumes in the total 6-mm ETDRS zone were recorded and analyzed using the ANCOVA test, adjusting for age. The mean CSFT in controls was 271 μm, while in the outpatient, ward-admitted, and ICU-admitted groups, it was 251, 260, and 253 μm, respectively (P = 0.093). No differences were observed in pRNFL between the groups (P> 0.1). However, the outer plexiform layer (OPL) was the only retinal sublayer that demonstrated a significant difference in 6-mm volume across the groups, with volumes of 0.832 μm in controls, 0.822 μm³ in the outpatients, 0.814 μm³ in ward-admitted patients, and 0.785 μm³ in ICU-admitted cases (P = 0.006). Our findings suggest that patients with severe COVID-19 illness, especially those requiring respiratory support, may develop ischemia and atrophy of the OPL. This indicates that the OPL might be the most vulnerable retinal sublayer to systemic hypoxemia, a hypothesis that requires confirmation through future studies.

References
1.
Wolf A, Khimani F, Yoon B, Gerhart C, Endsley D, Ray A . The mechanistic basis linking cytokine storm to thrombosis in COVID-19. Thromb Update. 2024; 8:100110. PMC: 9116969. DOI: 10.1016/j.tru.2022.100110. View

2.
Premi E, Acampora R, Salmi D, Ilie I, Pagnoncelli N, Germano F . Clinical and Diagnostic Findings of Acute Macular Neuroretinopathy and Paracentral Acute Middle Maculopathy in the COVID-19 Era. Ophthalmologica. 2023; 246(3-4):181-191. PMC: 10614461. DOI: 10.1159/000533530. View

3.
Yu D, Cringle S, Yu P, Su E . Intraretinal oxygen distribution and consumption during retinal artery occlusion and graded hyperoxic ventilation in the rat. Invest Ophthalmol Vis Sci. 2007; 48(5):2290-6. DOI: 10.1167/iovs.06-1197. View

4.
Bayram N, Gundogan M, Ozsaygili C, Adelman R . Posterior ocular structural and vascular alterations in severe COVID-19 patients. Graefes Arch Clin Exp Ophthalmol. 2021; 260(3):993-1004. PMC: 8488325. DOI: 10.1007/s00417-021-05420-9. View

5.
Lavia C, Bonnin S, Maule M, Erginay A, Tadayoni R, Gaudric A . VESSEL DENSITY OF SUPERFICIAL, INTERMEDIATE, AND DEEP CAPILLARY PLEXUSES USING OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY. Retina. 2018; 39(2):247-258. PMC: 6358199. DOI: 10.1097/IAE.0000000000002413. View